The Food and Drug Administration has approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow. The agency cleared Gazyva to fight chronic lymphocytic leukemia in combination with chemotherapy in patients who haven't previously been treated for the disease. Gazyva works by killing cancer cells and encouraging the immune system to fight against them. Read more here.
No comments:
Post a Comment